Elevance Health (ELV) Return on Capital Employed (2009 - 2026)

Elevance Health (ELV) has 18 years of Return on Capital Employed data on file, last reported at 3.16% in Q2 2026.

• On a quarterly basis, Return on Capital Employed rose 36.0% year-over-year to 3.16% in Q2 2026; TTM through Jun 2026 was 3.16%, a 36.0% increase from a year earlier, with the FY2025 full-year figure at 2.81%, down 3.0% from the prior year.
• Return on Capital Employed for Q2 2026 stood at 3.16%, up from 3.02% in the prior quarter.
• Over the last five years, Return on Capital Employed for ELV reached as high as 13.77% in Q1 2022 and fell as low as 2.29% in Q2 2023.
• Historically, Return on Capital Employed has averaged 4.39% across 5 years, with a median of 2.81% in 2024.
• Across the five-year window, Return on Capital Employed jumped 1215 bps in 2022 and plunged 989 bps in 2023, its largest moves.
• Year by year, Return on Capital Employed stood at 12.58% in 2022, then sank by 79 bps to 2.69% in 2023, then increased by 0 bps to 2.69% in 2024, then grew by 0 bps to 2.71% in 2025, then grew by 17 bps to 3.16% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 3.16% in Q2 2026, 3.02% in Q1 2026, and 2.71% in Q4 2025.